Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 7-8
Submit an article Journal homepage
207
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2

Carlos Cuadros Sáncheza Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, SpainCorrespondence[email protected]
View further author information
, MD,
Cristina Sacristán Egüena Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, SpainView further author information
, MD,
Raquel Gutierrez-Ezquerrob Department of Ophthalmology, University Torrevieja Hospital, Torrevieja, Alicante, EspañaView further author information
, MD,
Lena Giralt-Pereta Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, SpainView further author information
, MD &
Alex Fonollosaa Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain;c Department of Ophthalmology, Instituto Oftalmológico Bilbao, SpainView further author information
, MD, PHD
Pages 2010-2013 | Received 19 Apr 2021, Accepted 17 May 2021, Published online: 08 Jul 2021

References

  • Chen TY, Uppuluri A, Zarbin MA, Bhagat N. Risk factors for central retinal vein occlusion in young adults. Eur J Ophthalmol. 2020;112067212096033. doi:10.1177/1120672120960333.
  • World Health Organization. Covid19.who.int [Internet]. Spain: WHO Coronavirus Disease (COVID-19) Dashboard. 2020 [cited 2020 Oct 28]. Available from: https://covid19.who.int/region/euro/country/es
  • Devreese KMJ, Linskens EA, Benoit D, Peperstraete H. Antiphospholipid antibodies in patients with COVID-19: a relevant observation? J Thromb Haemost. 2020;18(9):2191–2201. doi:10.1111/jth.14994.
  • Xiao M, Zhang Y, Zhang S, et al. Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19. Arthritis & Rheumatology. 2020;72(12):1998–2004. doi:10.1002/art.41425.
  • Castillo-Martínez D, Torres Z, Amezcua-Guerra LM, Pineda C. Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19? Clin Rheumatol. 2021. doi:10.1007/s10067-021-05724-5.
  • Uludag G, Onghanseng N, Tran AN, et al. Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthalmic Inflamm Infect. 2021;11(1). doi:10.1186/s12348-021-00240-8.
  • Wu P, Duan F, Luo C, et al. Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291.
  • Rego Lorca D, Rouco Fernandez A, Jimenez Santos M, Saenz-Frances F, Burgos-Blasco B, Donate Lopez J. Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19. Acta Ophthalmol. 2020;1–2. doi:10.1111/aos.14536.
  • Gaba WH, Ahmed D, Al Nuaimi RK, Al Dhahani AA, Eatmadi H. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia. Am J Case Rep. 2020;21:e927691-1-e927691-5. doi:10.12659/AJCR.927691.
  • Sheth J, Narayanan R, Goyal J, Goyal V. Retinal vein occlusion in COVID-19: a novel entity. Indian J Ophthalmol. 2020;68(10):2291. doi:10.4103/ijo.IJO_2380_20.
  • Yahalomi T, Pikkel J, Arnon R, Pessach Y. Central retinal vein occlusion in a young healthy COVID-19 patient: a case report. Am J Ophthalmol Case Rep. 2020;20(November):100992. doi:10.1016/j.ajoc.2020.100992.
  • Walinjkar J, Makhija S, Sharma H, Morekar S, Natarajan S. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol. 2020;68(11):2572. doi:10.4103/ijo.IJO_2575_20.
  • Invernizzi A, Pellegrini M, Messenio D, et al. Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(8):1290–1292.
  • Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, López Vázquez Á, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state. Eur J Ophthalmol. 2020;112067212094759. doi:10.1177/1120672120947591.
  • Gascon P, Briantais A, Bertrand E, et al. Covid-19-Associated Retinopathy: a Case Report. Ocul Immunol Inflamm. 2020;28(8):1293–1297. doi:10.1080/09273948.2020.1825751.
  • Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Basingstoke). 2020;l:1–2.
  • Zamani G, Ataei Azimi S, Aminizadeh A, et al. Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report. J Ophthalmic Inflamm Infect. 2020;10(1):1–5. doi:10.1186/s12348-020-00231-1.
  • Benito-Pascual B, Gegúndez JA, Díaz-Valle D, et al. Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922–925. doi:10.1080/09273948.2020.1792512.
  • Landecho MF, Yuste JR, Gándara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2020;289(1):116–120.
  • Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine. 2020 Sep;27(January):100550. doi:10.1016/j.eclinm.2020.100550.
  • Rosés-Gibert P, Gimeno Castillo J, Saenz Aguirre A, et al. Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain. World J Pediatr. 2020;16(0123456789):1–4. doi:10.1007/s12519-020-00340-w.
  • Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum. 2002;31(4):256–263. doi:10.1053/sarh.2002.28303.
  • Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus. 2017;27(4):572–583. doi:10.1177/0961203317731532.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.